APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dual Orexin Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dual Orexin Receptor Antagonist Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchDual Orexin Receptor Antagonist Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Orexin Receptor Antagonist Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Dual Orexin Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Orexin Receptor Antagonist Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Orexin Receptor Antagonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dual Orexin Receptor Antagonist market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dual Orexin Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dual Orexin Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dual Orexin Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dual Orexin Receptor Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dual Orexin Receptor Antagonist include Idorsia, Merck and Eisal, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dual Orexin Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dual Orexin Receptor Antagonist, also provides the sales of main regions and countries. Of the upcoming market potential for Dual Orexin Receptor Antagonist, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dual Orexin Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dual Orexin Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dual Orexin Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.

Dual Orexin Receptor Antagonist Segment by Company

Idorsia

Merck

Eisal

Dual Orexin Receptor Antagonist Segment by Type

Suvorexant

Lemborexant

Daridorexant

Other

Dual Orexin Receptor Antagonist Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Dual Orexin Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Orexin Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Orexin Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Orexin Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dual Orexin Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dual Orexin Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dual Orexin Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Suvorexant Major Manufacturers Table 3. Lemborexant Major Manufacturers Table 4. Daridorexant Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital and Clinic Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Other Major Manufacturers Table 10. Dual Orexin Receptor Antagonist Industry Trends Table 11. Dual Orexin Receptor Antagonist Industry Drivers Table 12. Dual Orexin Receptor Antagonist Industry Opportunities and Challenges Table 13. Dual Orexin Receptor Antagonist Industry Restraints Table 14. Global Dual Orexin Receptor Antagonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Dual Orexin Receptor Antagonist Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Dual Orexin Receptor Antagonist Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2021-2026) Table 18. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2027-2032) Table 19. Global Dual Orexin Receptor Antagonist Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dual Orexin Receptor Antagonist Sales by Region (2021-2026) & (K Units) Table 21. Global Dual Orexin Receptor Antagonist Sales by Region (2027-2032) & (K Units) Table 22. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2021-2026) Table 23. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2027-2032) Table 24. Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Dual Orexin Receptor Antagonist Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2021-2026) Table 28. Global Dual Orexin Receptor Antagonist Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Dual Orexin Receptor Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Dual Orexin Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Dual Orexin Receptor Antagonist Manufacturers, Product Type & Application Table 32. Global Dual Orexin Receptor Antagonist Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Dual Orexin Receptor Antagonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Dual Orexin Receptor Antagonist Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2021-2026) Table 39. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2027-2032) Table 40. Global Dual Orexin Receptor Antagonist Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 42. Global Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 43. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2021-2026) Table 44. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2027-2032) Table 45. Global Dual Orexin Receptor Antagonist Price by Type (2021-2026) & (US$/Unit) Table 46. Global Dual Orexin Receptor Antagonist Price by Type (2027-2032) & (US$/Unit) Table 47. Global Dual Orexin Receptor Antagonist Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2021-2026) Table 51. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2027-2032) Table 52. Global Dual Orexin Receptor Antagonist Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 54. Global Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 55. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2021-2026) Table 56. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2027-2032) Table 57. Global Dual Orexin Receptor Antagonist Price by Application (2021-2026) & (US$/Unit) Table 58. Global Dual Orexin Receptor Antagonist Price by Application (2027-2032) & (US$/Unit) Table 59. Idorsia Company Information Table 60. Idorsia Business Overview Table 61. Idorsia Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Idorsia Dual Orexin Receptor Antagonist Product Portfolio Table 63. Idorsia Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Dual Orexin Receptor Antagonist Product Portfolio Table 68. Merck Recent Development Table 69. Eisal Company Information Table 70. Eisal Business Overview Table 71. Eisal Dual Orexin Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eisal Dual Orexin Receptor Antagonist Product Portfolio Table 73. Eisal Recent Development Table 74. North America Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 77. North America Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 78. North America Dual Orexin Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 79. North America Dual Orexin Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 80. North America Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 83. North America Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 84. North America Dual Orexin Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 85. North America Dual Orexin Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 86. North America Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 90. North America Dual Orexin Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 91. North America Dual Orexin Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 92. North America Dual Orexin Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 93. North America Dual Orexin Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 94. United States Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 95. Canada Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 96. Mexico Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 97. Europe Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 100. Europe Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 101. Europe Dual Orexin Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 102. Europe Dual Orexin Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 103. Europe Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 106. Europe Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 107. Europe Dual Orexin Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 108. Europe Dual Orexin Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 109. Europe Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. Europe Dual Orexin Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 114. Europe Dual Orexin Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 115. Europe Dual Orexin Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 116. Europe Dual Orexin Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 117. Germany Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 118. France Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 119. U.K. Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 120. Italy Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 121. Russia Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 122. Spain Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 124. Switzerland Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 125. Sweden Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 126. Poland Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 127. China Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 128. China Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 129. China Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 130. China Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 131. China Dual Orexin Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 132. China Dual Orexin Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 133. China Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 134. China Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 135. China Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 136. China Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 137. China Dual Orexin Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 138. China Dual Orexin Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 142. Asia Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 143. Asia Dual Orexin Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Asia Dual Orexin Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Asia Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 148. Asia Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 149. Asia Dual Orexin Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Asia Dual Orexin Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Asia Dual Orexin Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 156. Asia Dual Orexin Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 157. Asia Dual Orexin Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Asia Dual Orexin Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Japan Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 160. South Korea Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 161. India Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 162. Australia Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 163. Taiwan Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Dual Orexin Receptor Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Dual Orexin Receptor Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Dual Orexin Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 168. SAMEA Dual Orexin Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 169. SAMEA Dual Orexin Receptor Antagonist Sales Price by Type (2021-2026) & (US$/Unit) Table 170. SAMEA Dual Orexin Receptor Antagonist Sales Price by Type (2027-2032) & (US$/Unit) Table 171. SAMEA Dual Orexin Receptor Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Dual Orexin Receptor Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Dual Orexin Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 174. SAMEA Dual Orexin Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 175. SAMEA Dual Orexin Receptor Antagonist Sales Price by Application (2021-2026) & (US$/Unit) Table 176. SAMEA Dual Orexin Receptor Antagonist Sales Price by Application (2027-2032) & (US$/Unit) Table 177. SAMEA Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. SAMEA Dual Orexin Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 182. SAMEA Dual Orexin Receptor Antagonist Sales by Country (2027-2032) & (K Units) Table 183. SAMEA Dual Orexin Receptor Antagonist Sales Price by Country (2021-2026) & (US$/Unit) Table 184. SAMEA Dual Orexin Receptor Antagonist Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Brazil Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 186. Argentina Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 187. Chile Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 188. Colombia Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 189. Peru Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 191. Israel Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 192. UAE Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 193. Turkey Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 194. Iran Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 195. Egypt Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Dual Orexin Receptor Antagonist Distributors List Table 199. Dual Orexin Receptor Antagonist Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Dual Orexin Receptor Antagonist Image Figure 2. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dual Orexin Receptor Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 4. Suvorexant Image Figure 5. Lemborexant Image Figure 6. Daridorexant Image Figure 7. Other Image Figure 8. Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Dual Orexin Receptor Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital and Clinic Image Figure 11. Retail Pharmacies Image Figure 12. Other Image Figure 13. Global Dual Orexin Receptor Antagonist Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Dual Orexin Receptor Antagonist Revenue (2021-2032) & (US$ Million) Figure 15. Global Dual Orexin Receptor Antagonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2021-2032) Figure 18. Global Dual Orexin Receptor Antagonist Sales (2021-2032) & (K Units) Figure 19. Global Dual Orexin Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Dual Orexin Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 22. Europe Dual Orexin Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 23. China Dual Orexin Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Dual Orexin Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Dual Orexin Receptor Antagonist Sales YoY (2021-2032) & (K Units) Figure 26. Global Dual Orexin Receptor Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Dual Orexin Receptor Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Dual Orexin Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2021-2032) Figure 32. Global Dual Orexin Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Dual Orexin Receptor Antagonist Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2021-2032) Figure 35. Global Dual Orexin Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2021-2032) Figure 38. Global Dual Orexin Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Dual Orexin Receptor Antagonist Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2021-2032) Figure 41. North America Dual Orexin Receptor Antagonist Revenue Share by Type (2021-2032) Figure 42. North America Dual Orexin Receptor Antagonist Sales Share by Type (2021-2032) Figure 43. North America Dual Orexin Receptor Antagonist Revenue Share by Application (2021-2032) Figure 44. North America Dual Orexin Receptor Antagonist Sales Share by Application (2021-2032) Figure 45. North America Dual Orexin Receptor Antagonist Revenue Share by Country (2021-2032) Figure 46. North America Dual Orexin Receptor Antagonist Sales Share by Country (2021-2032) Figure 47. Europe Dual Orexin Receptor Antagonist Revenue Share by Type (2021-2032) Figure 48. Europe Dual Orexin Receptor Antagonist Sales Share by Type (2021-2032) Figure 49. Europe Dual Orexin Receptor Antagonist Revenue Share by Application (2021-2032) Figure 50. Europe Dual Orexin Receptor Antagonist Sales Share by Application (2021-2032) Figure 51. Europe Dual Orexin Receptor Antagonist Revenue Share by Country (2021-2032) Figure 52. Europe Dual Orexin Receptor Antagonist Sales Share by Country (2021-2032) Figure 53. China Dual Orexin Receptor Antagonist Revenue Share by Type (2021-2032) Figure 54. China Dual Orexin Receptor Antagonist Sales Share by Type (2021-2032) Figure 55. China Dual Orexin Receptor Antagonist Revenue Share by Application (2021-2032) Figure 56. China Dual Orexin Receptor Antagonist Sales Share by Application (2021-2032) Figure 57. Asia Dual Orexin Receptor Antagonist Revenue Share by Type (2021-2032) Figure 58. Asia Dual Orexin Receptor Antagonist Sales Share by Type (2021-2032) Figure 59. Asia Dual Orexin Receptor Antagonist Revenue Share by Application (2021-2032) Figure 60. Asia Dual Orexin Receptor Antagonist Sales Share by Application (2021-2032) Figure 61. Asia Dual Orexin Receptor Antagonist Revenue Share by Country (2021-2032) Figure 62. Asia Dual Orexin Receptor Antagonist Sales Share by Country (2021-2032) Figure 63. SAMEA Dual Orexin Receptor Antagonist Revenue Share by Type (2021-2032) Figure 64. SAMEA Dual Orexin Receptor Antagonist Sales Share by Type (2021-2032) Figure 65. SAMEA Dual Orexin Receptor Antagonist Revenue Share by Application (2021-2032) Figure 66. SAMEA Dual Orexin Receptor Antagonist Sales Share by Application (2021-2032) Figure 67. SAMEA Dual Orexin Receptor Antagonist Revenue Share by Country (2021-2032) Figure 68. SAMEA Dual Orexin Receptor Antagonist Sales Share by Country (2021-2032) Figure 69. Dual Orexin Receptor Antagonist Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dual Orexin Receptor Antagonist Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Suvorexant
  • Lemborexant
  • Daridorexant
  • Other
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Idorsia
  • Merck
  • Eisal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dual Orexin Receptor Antagonist Market by Type
  3. 1.2.1 Global Dual Orexin Receptor Antagonist Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Suvorexant
  5. 1.2.3 Lemborexant
  6. 1.2.4 Daridorexant
  7. 1.2.5 Other
  8. 1.3 Dual Orexin Receptor Antagonist Market by Application
  9. 1.3.1 Global Dual Orexin Receptor Antagonist Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital and Clinic
  11. 1.3.3 Retail Pharmacies
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Dual Orexin Receptor Antagonist Market Dynamics
  1. 2.1 Dual Orexin Receptor Antagonist Industry Trends
  2. 2.2 Dual Orexin Receptor Antagonist Industry Drivers
  3. 2.3 Dual Orexin Receptor Antagonist Industry Opportunities and Challenges
  4. 2.4 Dual Orexin Receptor Antagonist Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dual Orexin Receptor Antagonist Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dual Orexin Receptor Antagonist Revenue by Region
  3. 3.2.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dual Orexin Receptor Antagonist Revenue by Region (2021-2026)
  5. 3.2.3 Global Dual Orexin Receptor Antagonist Revenue by Region (2027-2032)
  6. 3.2.4 Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dual Orexin Receptor Antagonist Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dual Orexin Receptor Antagonist Sales by Region
  9. 3.4.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dual Orexin Receptor Antagonist Sales by Region (2021-2026)
  11. 3.4.3 Global Dual Orexin Receptor Antagonist Sales by Region (2027-2032)
  12. 3.4.4 Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers
  2. 4.1.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dual Orexin Receptor Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dual Orexin Receptor Antagonist Sales by Manufacturers
  6. 4.2.1 Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dual Orexin Receptor Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dual Orexin Receptor Antagonist Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dual Orexin Receptor Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dual Orexin Receptor Antagonist Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dual Orexin Receptor Antagonist Manufacturers, Product Type & Application
  13. 4.7 Global Dual Orexin Receptor Antagonist Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dual Orexin Receptor Antagonist Market CR5 and HHI
  16. 4.8.2 2025 Dual Orexin Receptor Antagonist Tier 1, Tier 2, and Tier 3
5 Dual Orexin Receptor Antagonist Market by Type
  1. 5.1 Global Dual Orexin Receptor Antagonist Revenue by Type
  2. 5.1.1 Global Dual Orexin Receptor Antagonist Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dual Orexin Receptor Antagonist Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dual Orexin Receptor Antagonist Sales by Type
  6. 5.2.1 Global Dual Orexin Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dual Orexin Receptor Antagonist Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dual Orexin Receptor Antagonist Price by Type
6 Dual Orexin Receptor Antagonist Market by Application
  1. 6.1 Global Dual Orexin Receptor Antagonist Revenue by Application
  2. 6.1.1 Global Dual Orexin Receptor Antagonist Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dual Orexin Receptor Antagonist Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dual Orexin Receptor Antagonist Sales by Application
  6. 6.2.1 Global Dual Orexin Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dual Orexin Receptor Antagonist Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dual Orexin Receptor Antagonist Price by Application
7 Company Profiles
  1. 7.1 Idorsia
  2. 7.1.1 Idorsia Company Information
  3. 7.1.2 Idorsia Business Overview
  4. 7.1.3 Idorsia Dual Orexin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Idorsia Dual Orexin Receptor Antagonist Product Portfolio
  6. 7.1.5 Idorsia Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Dual Orexin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Dual Orexin Receptor Antagonist Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eisal
  14. 7.3.1 Eisal Company Information
  15. 7.3.2 Eisal Business Overview
  16. 7.3.3 Eisal Dual Orexin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eisal Dual Orexin Receptor Antagonist Product Portfolio
  18. 7.3.5 Eisal Recent Developments
8 North America
  1. 8.1 North America Dual Orexin Receptor Antagonist Market Size by Type
  2. 8.1.1 North America Dual Orexin Receptor Antagonist Revenue by Type (2021-2032)
  3. 8.1.2 North America Dual Orexin Receptor Antagonist Sales by Type (2021-2032)
  4. 8.1.3 North America Dual Orexin Receptor Antagonist Price by Type (2021-2032)
  5. 8.2 North America Dual Orexin Receptor Antagonist Market Size by Application
  6. 8.2.1 North America Dual Orexin Receptor Antagonist Revenue by Application (2021-2032)
  7. 8.2.2 North America Dual Orexin Receptor Antagonist Sales by Application (2021-2032)
  8. 8.2.3 North America Dual Orexin Receptor Antagonist Price by Application (2021-2032)
  9. 8.3 North America Dual Orexin Receptor Antagonist Market Size by Country
  10. 8.3.1 North America Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dual Orexin Receptor Antagonist Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dual Orexin Receptor Antagonist Market Size by Type
  2. 9.1.1 Europe Dual Orexin Receptor Antagonist Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dual Orexin Receptor Antagonist Sales by Type (2021-2032)
  4. 9.1.3 Europe Dual Orexin Receptor Antagonist Price by Type (2021-2032)
  5. 9.2 Europe Dual Orexin Receptor Antagonist Market Size by Application
  6. 9.2.1 Europe Dual Orexin Receptor Antagonist Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dual Orexin Receptor Antagonist Sales by Application (2021-2032)
  8. 9.2.3 Europe Dual Orexin Receptor Antagonist Price by Application (2021-2032)
  9. 9.3 Europe Dual Orexin Receptor Antagonist Market Size by Country
  10. 9.3.1 Europe Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dual Orexin Receptor Antagonist Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dual Orexin Receptor Antagonist Market Size by Type
  2. 10.1.1 China Dual Orexin Receptor Antagonist Revenue by Type (2021-2032)
  3. 10.1.2 China Dual Orexin Receptor Antagonist Sales by Type (2021-2032)
  4. 10.1.3 China Dual Orexin Receptor Antagonist Price by Type (2021-2032)
  5. 10.2 China Dual Orexin Receptor Antagonist Market Size by Application
  6. 10.2.1 China Dual Orexin Receptor Antagonist Revenue by Application (2021-2032)
  7. 10.2.2 China Dual Orexin Receptor Antagonist Sales by Application (2021-2032)
  8. 10.2.3 China Dual Orexin Receptor Antagonist Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dual Orexin Receptor Antagonist Market Size by Type
  2. 11.1.1 Asia Dual Orexin Receptor Antagonist Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dual Orexin Receptor Antagonist Sales by Type (2021-2032)
  4. 11.1.3 Asia Dual Orexin Receptor Antagonist Price by Type (2021-2032)
  5. 11.2 Asia Dual Orexin Receptor Antagonist Market Size by Application
  6. 11.2.1 Asia Dual Orexin Receptor Antagonist Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dual Orexin Receptor Antagonist Sales by Application (2021-2032)
  8. 11.2.3 Asia Dual Orexin Receptor Antagonist Price by Application (2021-2032)
  9. 11.3 Asia Dual Orexin Receptor Antagonist Market Size by Country
  10. 11.3.1 Asia Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dual Orexin Receptor Antagonist Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dual Orexin Receptor Antagonist Market Size by Type
  2. 12.1.1 SAMEA Dual Orexin Receptor Antagonist Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dual Orexin Receptor Antagonist Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dual Orexin Receptor Antagonist Price by Type (2021-2032)
  5. 12.2 SAMEA Dual Orexin Receptor Antagonist Market Size by Application
  6. 12.2.1 SAMEA Dual Orexin Receptor Antagonist Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dual Orexin Receptor Antagonist Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dual Orexin Receptor Antagonist Price by Application (2021-2032)
  9. 12.3 SAMEA Dual Orexin Receptor Antagonist Market Size by Country
  10. 12.3.1 SAMEA Dual Orexin Receptor Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dual Orexin Receptor Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dual Orexin Receptor Antagonist Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dual Orexin Receptor Antagonist Value Chain Analysis
  2. 13.1.1 Dual Orexin Receptor Antagonist Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dual Orexin Receptor Antagonist Production Mode & Process
  6. 13.2 Dual Orexin Receptor Antagonist Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dual Orexin Receptor Antagonist Distributors
  9. 13.2.3 Dual Orexin Receptor Antagonist Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst